Effect of Unani Treatment in Lichen Planus

Efficacy of Majoon and Tila Barse Aswad in Lichen planus - An open labelled single arm clinical study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/031016

Enrollment

Registered

2021-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L439- Lichen planus, unspecified

Interventions

Intervention1: Majoon for oral intake and Tila Barse Aswad for Local application: All the ingredients of Majoon(Haleela kabli,Haleela Siyah,Aftimoon,Maweez munaqqa)in Equal quantity are ground and sie

Eligibility

Inclusion criteria

Inclusion criteria: 1.Cases of Lichen Planus. 2.Patients of both genders. 3.Patients in the age group of 18 years to 60 years. 4.Patients are willing to be a part of our study.

Exclusion criteria

Exclusion criteria: 1.Patient below and above the age of 18 years and 60 years. 2.Patient suffering from any other type of skin diseases like psoriasis, Eczema, Seborrheic Dermatitis, dermatophytosis, LSC and Lupus Erythematosus. 3.Patient suffering from systemic and metabolic diseases like DM, severe asthma, Cardiac diseases, Chronic Renal failure. 4.Pregnant & Lactating Women. 5.Patients are not willing to be a part of study.

Design outcomes

Primary

Measure	Time frame
1.Lichen Planus Severity Index18 2.Investigator assessment using Photograph 3.Itching Severity on VAS20 Timepoint: At Baseline and at 6th week	—

Secondary

Measure	Time frame
1.Dermatological Life Quality Index (DLQI)Timepoint: At Baseline and 6th week	—

Countries

India

Contacts

Public ContactSumbul Nida

National Institute of Unani Medicine

mansoorsiddiquidr@gmail.com9448124054

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026